Millipore Sigma Vibrant Logo

688000 Y-27632 - CAS 331752-47-7 - Calbiochem

Y-27632, CAS 146986-50-7, is a cell-permeable, reversible, inhibitor of Rho kinases (Ki = 140 nM for p160ROCK). Enhances survival & cloning efficiency of ESC without affecting their pluripotency.

Y-27632 - CAS 331752-47-7 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: ROCK Inhibitor, (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl, Rho Kinase Inhibitor VI

Primary Target: p160 Rho-associated protein kinases (ROCK)
View This Product on Sigma-Aldrich
688000
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
331752-47-7C₁₄H₂₁N₃O · 2HCl · H₂O

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
688000-100MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      688000-10MGCN
      在庫状況検索中…
      —
      現在国内在庫なし 現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          		 ｶﾞﾗｽﾋﾞﾝ 10 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          弊社照会 詳細を表示　
          値引
          ()
           
          —
          弊社照会
          		 —
          688000-1MGCN
          在庫状況検索中…
          —
          現在国内在庫なし 現在国内在庫なし
          現在国内在庫有り 
          販売中止
          在庫僅少
          現在国内在庫あり
            Remaining : Will advise
              Remaining : Will advise
              注文対象外
              お問合せください
              Contact Customer Service

              		 樹脂ｱﾝﾌﾟﾙ 1 mg
              価格を検索中…
              価格が見つかりません
              Minimum Quantity needs to be mulitiple of
              Maximum Quantity is
              弊社照会 詳細を表示　
              値引
              ()
               
              —
              弊社照会
              		 —
              688000-5MGCN
              在庫状況検索中…
              —
              現在国内在庫なし 現在国内在庫なし
              現在国内在庫有り 
              販売中止
              在庫僅少
              現在国内在庫あり
                Remaining : Will advise
                  Remaining : Will advise
                  注文対象外
                  お問合せください
                  Contact Customer Service

                  		 ｶﾞﾗｽﾋﾞﾝ 5 mg
                  価格を検索中…
                  価格が見つかりません
                  Minimum Quantity needs to be mulitiple of
                  Maximum Quantity is
                  弊社照会 詳細を表示　
                  値引
                  ()
                   
                  —
                  弊社照会
                  		 —
                  Description
                  OverviewA highly potent, cell-permeable, reversible, and selective inhibitor of Rho-associated protein kinases (Ki = 140 nM for p160ROCK). Also inhibits ROCK-II with equal potency. The inhibition is competitive with respect to ATP. Exhibits 10- to 50-fold lower affinity for PKCε than p160ROCK. Does not affect the activity of p21-activated protein kinase (PAK) even at higher concentrations (~100 µM). Also acts as a potent inhibitor of agonist-induced Ca2+ sensitization of myosin phosphorylation and smooth muscle contraction. Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency. Pretreatment with Y-27632 reduces the risk of lung injury in rat models of sepsis. A 5 mM (500 µg/296 µl) solution of Y-27632 (Cat. No. 688001) in H2O and a 10 mM solution in DMSO (Cat. No. 688002) are also available.
                  Catalogue Number688000
                  Brand Family Calbiochem®
                  SynonymsROCK Inhibitor, (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl, Rho Kinase Inhibitor VI
                  References
                  ReferencesCinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
                  Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
                  Chitaley, K., et al. 2001. Nat. Med. 7, 119.
                  Davies, S.P., et al. 2000. Biochem. J. 351, 95.
                  Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
                  Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
                  Maekawa, M., et al. 1999. Science 285, 895.
                  Uehata, M., et al. 1997. Nature 389, 990.
                  Product Information
                  CAS number331752-47-7
                  ATP CompetitiveY
                  DeclarationSold under license of PCT Application W098/06,433A1 and under license from Mitsubishi Pharma Tanabe Corporation.
                  FormWhite solid
                  Hill FormulaC₁₄H₂₁N₃O · 2HCl · H₂O
                  Chemical formulaC₁₄H₂₁N₃O · 2HCl · H₂O
                  Hygroscopic Hygroscopic
                  ReversibleY
                  Structure formula ImageStructure formula Image
                  Quality LevelMQ100
                  Applications
                  ApplicationY-27632, CAS 146986-50-7, is a cell-permeable, reversible, inhibitor of Rho kinases (Ki = 140 nM for p160ROCK). Enhances survival & cloning efficiency of ESC without affecting their pluripotency.
                  Biological Information
                  Primary Targetp160 Rho-associated protein kinases (ROCK)
                  Primary Target K<sub>i</sub>140 nM for p160 Rho-associated protein kinases (ROCK)
                  Purity≥95% by HPLC
                  Physicochemical Information
                  Cell permeableY
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  R PhraseR: 20/21/22

                  Harmful by inhalation, in contact with skin and if swallowed.
                  S PhraseS: 36

                  Wear suitable protective clothing.
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Ambient Temperature Only
                  Toxicity Harmful
                  Storage -20°C
                  Protect from Light Protect from light
                  Hygroscopic Hygroscopic
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 6 months at -20°C.
                  Packaging Information
                  Packaged under inert gas Packaged under inert gas
                  Transport Information
                  Supplemental Information
                  Specifications
                  Global Trade Item Number
                  カタログ番号 GTIN
                  688000-100MGCN 04055977225402
                  688000-10MGCN 04055977225396
                  688000-1MGCN 07790788052362
                  688000-5MGCN 07790788052379

                  Documentation

                  Y-27632 - CAS 331752-47-7 - Calbiochem (M)SDS

                  タイトル

                  英語版製品安全データシート（(M)SDS） 

                  Y-27632 - CAS 331752-47-7 - Calbiochem 試験成績書（CoA）

                  タイトルロット番号
                  688000

                  参考資料

                  参考資料の概要
                  Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
                  Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
                  Chitaley, K., et al. 2001. Nat. Med. 7, 119.
                  Davies, S.P., et al. 2000. Biochem. J. 351, 95.
                  Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
                  Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
                  Maekawa, M., et al. 1999. Science 285, 895.
                  Uehata, M., et al. 1997. Nature 389, 990.

                  カタログ

                  タイトル
                  Bulk Product Guide
                  メルクミリポアが自信をもってお届けする ES/iPS 細胞関連製品＆がん幹細胞関連新製品

                  データシート

                  タイトル
                  Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

                  引用

                  Title
                • Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
                • Jennifer L. Farmer, et al. (2008) Galectin 15 (LGALS15) functions in trophectoderm migration and attachment. Federation of American Societies for Experimental Biology Journal 22, 548-560.
                • James J. Fiordalisi, Patricia J. Keller and Adrienne D. Cox. (2006) PRL Tyrosine Phosphatases Regulate Rho Family GTPases to Promote Invasion and Motility. Cancer Research 66, 3153-3161.
                • Karen E. Porter, et al. (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovascular Research 61, 745-755.
                • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
                  		•
                  データシート

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision27-February-2012 RFH
                  SynonymsROCK Inhibitor, (R)-(+)-trans-N-(4-Pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide, 2HCl, Rho Kinase Inhibitor VI
                  DescriptionA highly potent, cell-permeable, reversible, and selective inhibitor of Rho-associated protein kinase (Ki = 140 nM for p160ROCK (ROCK-I). Also inhibits ROCK-II with almost equal potency. Inhibition is achieved by competing with ATP for binding to the catalytic site. Exhibits 10- to 50-fold lower affinity for PKCε than p160ROCK. Does not affect the activity of p21-activated protein kinase (PAK) even at high concentrations (~100 µM). Also acts as a potent inhibitor of agonist-induced Ca2+ sensitization of myosin phosphorylation and smooth muscle contractions (IC50 = 700 nM for phenylephrine-induced contractions in aortic strips). Prevents apoptosis and enhances the survival and cloning efficiency of dissociated hES cells without affecting their pluripotency. Pretreatment with Y-27632 reduces the risk of lung injury in rat models of sepsis.
                  FormWhite solid
                  Intert gas (Yes/No) Packaged under inert gas
                  CAS number331752-47-7
                  Chemical formulaC₁₄H₂₁N₃O · 2HCl · H₂O
                  Structure formulaStructure formula
                  Purity≥95% by HPLC
                  SolubilityH₂O (100 mg/ml)
                  Storage Protect from light
                  -20°C
                  Hygroscopic
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 6 months at -20°C.
                  Toxicity Harmful
                  ReferencesCinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
                  Watanabe, K., et al. 2007. Nature Biotech. 25, 681.
                  Chitaley, K., et al. 2001. Nat. Med. 7, 119.
                  Davies, S.P., et al. 2000. Biochem. J. 351, 95.
                  Narumiya, S., et al. 2000. Methods Enzymol. 325, 273.
                  Hirose, M., et al. 1998. J. Cell Biol. 141, 1625.
                  Maekawa, M., et al. 1999. Science 285, 895.
                  Uehata, M., et al. 1997. Nature 389, 990.
                  Citation
                • Cinel, I., et al. 2012. J. Thorac . Dis. 4, 30.
                • Jennifer L. Farmer, et al. (2008) Galectin 15 (LGALS15) functions in trophectoderm migration and attachment. Federation of American Societies for Experimental Biology Journal 22, 548-560.
                • James J. Fiordalisi, Patricia J. Keller and Adrienne D. Cox. (2006) PRL Tyrosine Phosphatases Regulate Rho Family GTPases to Promote Invasion and Motility. Cancer Research 66, 3153-3161.
                • Karen E. Porter, et al. (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovascular Research 61, 745-755.
                • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
                  		•